| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Immunoglobulin M | 100 | + | |
2 | Zidovudine | 34 | + | |
3 | Foscarnet | 24 | + | |
4 | Pentamidine | 20 | + | |
5 | Phosphonoacetic Acid | 17 | + | |
6 | Retroviridae Proteins | 16 | + | |
7 | HIV Antibodies | 15 | + | |
8 | Zalcitabine | 15 | + | |
9 | Ganciclovir | 13 | + | |
10 | Didanosine | 12 | + | |
11 | HIV Core Protein p24 | 12 | + | |
12 | Organophosphorus Compounds | 10 | + | |
13 | Tetrahydrouridine | 10 | + | |
14 | Tungsten | 10 | + | |
15 | Trimethoprim-Sulfamethoxazole Combination | 9 | + | |
16 | Suramin | 8 | + | |
17 | RNA-Directed DNA Polymerase | 8 | + | |
18 | Fluconazole | 8 | + | |
19 | Tungsten Compounds | 7 | + | |
20 | Acyclovir | 7 | + | |
21 | RNA, Viral | 7 | + | |
22 | Antibodies, Viral | 7 | + | |
23 | AIDS Vaccines | 7 | + | |
24 | Gene Products, gag | 6 | + | |
25 | Cytosine | 6 | + | |
26 | Ketoconazole | 6 | + | |
27 | Immunoglobulins, Intravenous | 6 | + | |
28 | HIV Envelope Protein gp120 | 6 | + | |
29 | Organophosphonates | 6 | + | |
30 | tat Gene Products, Human Immunodeficiency Virus | 6 | + | |
31 | SAIDS Vaccines | 6 | + | |
32 | DNA, Viral | 6 | + | |
33 | Amidines | 6 | + | |
34 | Megestrol Acetate | 5 | + | |
35 | Recombinant Proteins | 5 | + | |
36 | Itraconazole | 5 | + | |
37 | Interleukin-2 | 5 | + | |
38 | Amphotericin B | 5 | + | |
39 | Gene Products, env | 5 | + | |
40 | Interferon Type I | 4 | + | |
41 | HIV Reverse Transcriptase | 4 | + | |
42 | Immunoglobulin G | 4 | + | |
43 | Prednisone | 4 | + | |
44 | Trimethoprim | 4 | + | |
45 | Sulfamethoxazole | 4 | + | |
46 | Colony-Stimulating Factors | 4 | + | |
47 | rev Gene Products, Human Immunodeficiency Virus | 4 | + | |
48 | HIV Protease | 3 | + | |
49 | Gene Products, tat | 3 | + | |
50 | env Gene Products, Human Immunodeficiency Virus | 3 | + | |
51 | Interferon-gamma | 3 | + | |
52 | Indinavir | 3 | + | |
53 | HIV Envelope Protein gp160 | 3 | + | |
54 | gag Gene Products, Human Immunodeficiency Virus | 3 | + | |
55 | Gene Products, rev | 3 | + | |
56 | Dideoxynucleosides | 3 | + | |
57 | nef Gene Products, Human Immunodeficiency Virus | 3 | + | |
58 | Gene Products, nef | 3 | + | |
59 | HIV Envelope Protein gp41 | 3 | + | |
60 | Dideoxynucleotides | 2 | + | |
61 | Adenine | 2 | + | |
62 | Ritonavir | 2 | + | |
63 | Receptors, CCR5 | 2 | + | |
64 | Codon | 2 | + | |
65 | Saquinavir | 2 | + | |
66 | Benzoxazines | 2 | + | |
67 | Nelfinavir | 2 | + | |
68 | Adenosine Deaminase | 2 | + | |
69 | Vaccines, Synthetic | 2 | + | |
70 | Human Immunodeficiency Virus Proteins | 2 | + | |
71 | Antigens, CD4 | 2 | + | |
72 | Pyrimidinones | 2 | + | |
73 | Vaccines, DNA | 2 | + | |
74 | Viral Vaccines | 2 | + | |
75 | Oxazines | 2 | + | |
76 | Immunoglobulins | 2 | + | |
77 | pol Gene Products, Human Immunodeficiency Virus | 2 | + | |
78 | vpr Gene Products, Human Immunodeficiency Virus | 2 | + | |
79 | Oligonucleotide Probes | 2 | + | |
80 | Lamivudine | 2 | + | |
81 | Viral Envelope Proteins | 2 | + | |
82 | Retroviridae Proteins, Oncogenic | 2 | + | |
83 | Stavudine | 2 | + | |
84 | Receptors, HIV | 1 | + | |
85 | DNA Primers | 1 | + | |
86 | Thymine Nucleotides | 1 | + | |
87 | Lopinavir | 1 | + | |
88 | Nevirapine | 1 | + | |
89 | Gene Products, vif | 1 | + | |
90 | Gene Products, pol | 1 | + | |
91 | Delavirdine | 1 | + | |
92 | Thymus Hormones | 1 | + | |
93 | Receptors, CXCR4 | 1 | + | |
94 | Thymus Extracts | 1 | + | |
95 | Carbamates | 1 | + | |
96 | Rifabutin | 1 | + | |
97 | Deoxyadenine Nucleotides | 1 | + | |
98 | Antibodies, Monoclonal | 1 | + | |
99 | Deoxycytosine Nucleotides | 1 | + | |
100 | Viral Proteins | 1 | + | |
101 | CD4 Immunoadhesins | 1 | + | |
102 | Peptide Fragments | 1 | + | |
103 | gamma-Globulins | 1 | + | |
104 | Vaccines, Attenuated | 1 | + | |
105 | vif Gene Products, Human Immunodeficiency Virus | 1 | + | |
106 | Cytokines | 1 | + | |
107 | Immunoglobulin A | 1 | + | |
108 | Antibodies, Neutralizing | 1 | + | |
109 | Pyridines | 1 | + | |
110 | Membrane Glycoproteins | 1 | + | |
111 | Isoniazid | 1 | + | |
112 | Chemokine CCL5 | 1 | + | |
113 | Neopterin | 1 | + | |
114 | Histocompatibility Antigens Class I | 1 | + | |
115 | Thymopoietins | 1 | + | |
116 | Glucocorticoids | 1 | + | |
117 | Oligopeptides | 1 | + | |
118 | HIV Integrase | 1 | + | |
119 | beta 2-Microglobulin | 1 | + | |
120 | Pyrrolidinones | 1 | + | |
121 | Sulfonic Acids | 1 | + | |
122 | Vaccines, Inactivated | 1 | + | |
123 | N-Glycosyl Hydrolases | 1 | + | |
124 | Interleukin-7 | 1 | + | |
125 | Thymine | 1 | + | |
126 | Steroids | 1 | + | |
127 | Deoxyadenosines | 1 | + | |
128 | Thymopentin | 1 | + | |
129 | Peptides | 1 | + | |
130 | Organophosphates | 1 | + | |
131 | Antigens, CD45 | 1 | + | |
132 | Adrenal Cortex Hormones | 1 | + | |
133 | Prednisolone | 1 | + | |
134 | Nonoxynol | 1 | + | |
135 | Phytohemagglutinins | 1 | + | |
136 | Sulfonamides | 1 | + | |
137 | Transmembrane Activator and CAML Interactor Protein | 1 | + | |